What is the recommended treatment for Brucella sacroiliitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Brucella Sacroiliitis

For Brucella sacroiliitis, treat with doxycycline 100 mg twice daily for 6 weeks combined with either streptomycin 15 mg/kg daily IM for 2-3 weeks OR rifampicin 600-900 mg daily for 6 weeks, with gentamicin 5 mg/kg daily for 7 days as an acceptable alternative to streptomycin. 1

Primary Treatment Regimens

The Ioannina Recommendations (2007) provide the definitive framework for treating osteoarticular brucellosis, including sacroiliitis. Two regimens receive the highest recommendation (AI - good evidence, should generally be offered):

First-Line Options:

  • Doxycycline-Streptomycin (DOX-STR): Doxycycline 100 mg PO twice daily for 6 weeks + Streptomycin 15 mg/kg IM daily for 2-3 weeks 1
  • Doxycycline-Rifampicin (DOX-RIF): Doxycycline 100 mg PO twice daily for 6 weeks + Rifampicin 600-900 mg PO daily (single morning dose) for 6 weeks 1

Alternative First-Line:

  • Doxycycline-Gentamicin (DOX-GENT): Doxycycline 100 mg PO twice daily for 6 weeks + Gentamicin 5 mg/kg IV/IM daily for 7 days (BI recommendation) 1

Clinical Reasoning

Sacroiliitis represents focal osteoarticular involvement requiring aggressive combination therapy. The evidence shows that sacroiliitis is associated with severe pain and represents one of the most common osteoarticular manifestations of brucellosis 2. Multiple case reports demonstrate successful treatment with these combination regimens 3, 4, 5, 6.

Why combination therapy is mandatory: Monotherapy with doxycycline alone, while showing similar relapse rates to DOX-RIF in some studies, carries relapse rates of 5-15% even in uncomplicated cases 1. Osteoarticular involvement increases relapse risk, making dual therapy non-negotiable.

Choosing Between Regimens

DOX-STR is considered the "gold standard" but has practical limitations:

  • Requires 2-3 weeks of daily IM injections
  • Streptomycin availability may be limited
  • Ototoxicity concerns with prolonged use

DOX-RIF offers convenience:

  • Entirely oral regimen
  • Better patient compliance
  • Equal efficacy to DOX-STR 1
  • Caution: In TB-endemic regions, rifampicin use for brucellosis may promote mycobacterial resistance 1

DOX-GENT provides a middle ground:

  • Only 7 days of parenteral therapy
  • Gentamicin more widely available than streptomycin
  • Spares streptomycin for TB treatment 1
  • Some evidence suggests gentamicin duration could be shortened to 5 days or extended to 14 days, though 7 days is standard 1

Treatment Duration and Monitoring

Standard duration is 6 weeks for doxycycline-based regimens. However, for osteoarticular brucellosis specifically, prolonged therapy may be necessary 2. Case reports document treatment extending to 3-12 months for complicated osteoarticular disease 5, 6.

If fever persists beyond 48-72 hours or symptoms worsen:

  • Consider adding gentamicin if not already included 6
  • Extend total treatment duration to 3 months minimum 2
  • Evaluate for abscess formation requiring drainage 5

Common Pitfalls to Avoid

  1. Don't use monotherapy: Even for isolated sacroiliitis, single-agent treatment has unacceptably high relapse rates (up to 46% with TMP-SMX) 1

  2. Don't stop treatment prematurely: Osteoarticular involvement requires longer courses than uncomplicated brucellosis. Stopping at 6 weeks may lead to relapse 2

  3. Don't miss the diagnosis: In endemic areas or with travel history, maintain high suspicion for brucellosis in patients with sacroiliitis and constitutional symptoms 3, 4, 6

  4. Don't forget imaging follow-up: MRI is essential for documenting resolution and detecting complications like abscess formation 5

Special Considerations

For treatment failures or relapses: The same regimens can be used successfully, though consider extending duration and ensuring compliance 1. If rifampicin was used initially and caused intolerance, ciprofloxacin can substitute, though fluoroquinolones are second-line (CII recommendation) 6.

Surgical intervention: Rarely needed for sacroiliitis unless abscess formation occurs or there is joint instability requiring fusion 7.

References

Research

Current therapeutic strategy in osteoarticular brucellosis.

Northern clinics of Istanbul, 2019

Research

Brucellosis and sacroiliitis: a common presentation of an uncommon pathogen.

Journal of the American Board of Family Medicine : JABFM, 2008

Research

A case of brucellosis with abscess of the iliacus muscle, olecranon bursitis, and sacroiliitis.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2009

Research

[Brucellosis as an imported disease in a young man with arthritis].

Nederlands tijdschrift voor geneeskunde, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.